Hos patienter med tidligere tilfælde af leverdysfunktion herunder kronisk aktiv hepatitis er der en forhøjet forekomst af unormal leverfunktion under antiretroviral kombinationsbehandling og disse patienter bør overvåges i henhold til standardprocedurer.
Patients with pre-existing liver dysfunction including chronic active hepatitis have an increased frequency of liver function abnormalities during combination antiretroviral therapy and should be monitored according to standard practice.